Search results: Sage Journals

Restricted accessResearch articleFirst published September, 2025

Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?

Jan Kehler, Morten Skøtt Thomsen Lindskov

Journal of Psychopharmacology

Restricted accessReview articleFirst published 2026

Classic psychedelics and personality: An updated systematic review

Anna Beatriz Vicentini, Caio César de Paula, José Augusto Silva Reis [...]

Journal of Psychopharmacology

Restricted accessReview articleFirst published September, 2025

A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction

Dillon L Glenn, Seung Hee Choi, Rick S Zimmerman

Journal of Psychopharmacology

Restricted accessResearch articleFirst published January, 2023

Belief changes associated with psychedelic use

Sandeep M. Nayak, Manvir Singh, David B. Yaden [...]

Journal of Psychopharmacology

Restricted accessResearch articleFirst published December, 2013

5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus

Valquíria Camin de Bortoli, Paula Shimene de Melo Yamashita, Hélio Zangrossi

Journal of Psychopharmacology

Restricted accessResearch articleFirst published May, 2000

Chronic administration of the cholesterol reducing drug gemfibrozil fails to alter 5-HT1A and 5-HT2A mediated receptor behaviours in rats

Andrew C. McCreary, Sheila L. Handley

Journal of Psychopharmacology

Free accessReview articleFirst published April, 2016

Multiple D2 heteroreceptor complexes: new targets for treatment of schizophrenia

Dasiel O. Borroto-Escuela, Julia Pintsuk, Thorsten Schäfer [...]

Therapeutic Advances in Psychopharmacology

Restricted accessOtherFirst published August, 2008

Human hallucinogen research: guidelines for safety

MW Johnson, WA Richards, RR Griffiths

Journal of Psychopharmacology

Restricted accessResearch articleFirst published July, 2000

Manipulation of operant responding for an ethanol-paired conditioned stimulus in the rat by pharmacological alteration of the serotonergic system

A. W. Wilson, B. Costall, J. C. Neill

Journal of Psychopharmacology

Open accessResearch articleFirst published 2018

Behavioral Mechanisms That Depend on Dopamine and Serotonin in Caenorhabditis elegans Interact With the Antipsychotics Risperidone and Aripiprazole

Jaime Osuna-Luque, Ángel Rodríguez-Ramos, María del Mar Gámez-del-Estal [...]

Neuroscience Insights

Restricted accessResearch articleFirst published September, 2025

Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin 5-HT2A receptor agonists?

Jan Kehler, Morten Skøtt Thomsen Lindskov

Journal of Psychopharmacology

Restricted accessReview articleFirst published 2026

Classic psychedelics and personality: An updated systematic review

Anna Beatriz Vicentini, Caio César de Paula, José Augusto Silva Reis [...]

Journal of Psychopharmacology

Restricted accessReview articleFirst published September, 2025

A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction

Dillon L Glenn, Seung Hee Choi, Rick S Zimmerman

Journal of Psychopharmacology

Restricted accessResearch articleFirst published January, 2023

Belief changes associated with psychedelic use

Sandeep M. Nayak, Manvir Singh, David B. Yaden [...]

Journal of Psychopharmacology

Restricted accessResearch articleFirst published December, 2013

5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus

Valquíria Camin de Bortoli, Paula Shimene de Melo Yamashita, Hélio Zangrossi

Journal of Psychopharmacology

Restricted accessResearch articleFirst published May, 2000

Chronic administration of the cholesterol reducing drug gemfibrozil fails to alter 5-HT1A and 5-HT2A mediated receptor behaviours in rats

Andrew C. McCreary, Sheila L. Handley

Journal of Psychopharmacology

Free accessReview articleFirst published April, 2016

Multiple D2 heteroreceptor complexes: new targets for treatment of schizophrenia

Dasiel O. Borroto-Escuela, Julia Pintsuk, Thorsten Schäfer [...]

Therapeutic Advances in Psychopharmacology

Restricted accessOtherFirst published August, 2008

Human hallucinogen research: guidelines for safety

MW Johnson, WA Richards, RR Griffiths

Journal of Psychopharmacology

Restricted accessResearch articleFirst published July, 2000

Manipulation of operant responding for an ethanol-paired conditioned stimulus in the rat by pharmacological alteration of the serotonergic system

A. W. Wilson, B. Costall, J. C. Neill

Journal of Psychopharmacology

Open accessResearch articleFirst published 2018

Behavioral Mechanisms That Depend on Dopamine and Serotonin in Caenorhabditis elegans Interact With the Antipsychotics Risperidone and Aripiprazole

Jaime Osuna-Luque, Ángel Rodríguez-Ramos, María del Mar Gámez-del-Estal [...]

Neuroscience Insights